Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extensionMult. Scler. 2021 Sep 09;[EPub Ahead of Print], SJ Pittock, K Fujihara, J Palace, A Berthele, HJ Kim, C Oreja-Guevara, I Nakashima, M Levy, S Shang, M Yountz, L Miller, R Armstrong, DM Wingerchuk
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.